Stocks and Investing Stocks and Investing
Tue, May 16, 2023

Joseph Pantginis Reiterated (ATNM) at Strong Buy and Held Target at $53 on, May 16th, 2023


Published on 2024-10-28 03:48:05 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Reiterated "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy and Held Target at $53 on, May 16th, 2023.

Joseph has made no other calls on ATNM in the last 4 months.



There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, all agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andy Hsieh of "William Blair" Downgraded from Buy to Hold on, Tuesday, February 21st, 2023
Contributing Sources